BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3979846)

  • 1. Vitreous fluorophotometry in diabetics: study of artifactual contributions.
    Delori FC; Bursell SE; Yoshida A; McMeel JW
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):215-8. PubMed ID: 3979846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the technique of vitreous fluorophotometry.
    Zeimer RC; Cunha-Vaz JG; Johnson ME
    Invest Ophthalmol Vis Sci; 1982 May; 22(5):668-74. PubMed ID: 7076410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical variables in vitreous fluorophotometry.
    Conway BP
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):194-201. PubMed ID: 3979842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterior vitreous fluorophotometry. II. Comparison of diabetic patients and controls with the use of a new analysis procedure.
    Roy MS; Bungay PM; Bonner RF
    Arch Ophthalmol; 1989 Sep; 107(9):1328-33. PubMed ID: 2675803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of retinal involvement in diabetes by vitreous fluorophotometry.
    Cunha-Vaz JG; Goldberg MF; Vygantas C; Noth J
    Ophthalmology; 1979 Feb; 86(2):264-75. PubMed ID: 530578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting vitreous fluorescence.
    Mosier MA
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):202-5. PubMed ID: 3979843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous fluorophotometry in rats with streptozocin-induced diabetes.
    Vine AK; Kisly AM; Betz AL; Howatt WF
    Arch Ophthalmol; 1984 Jul; 102(7):1083-5. PubMed ID: 6743087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry.
    Cunha-Vaz JG; Gray JR; Zeimer RC; Mota MC; Ishimoto BM; Leite E
    Diabetes; 1985 Jan; 34(1):53-9. PubMed ID: 3964755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
    Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
    Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous fluorophotometry: identification of sources of variability.
    Prager TC; Wilson DJ; Avery GD; Merritt JH; Garcia CA; Hopen G; Anderson RE
    Invest Ophthalmol Vis Sci; 1981 Dec; 21(6):854-64. PubMed ID: 7309436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous fluorophotometry studies in aphakia.
    Quentel G; Zerah I; Coscas G
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):248-9. PubMed ID: 3979852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous fluorophotometry studies in retinitis pigmentosa.
    Travassos A; Fishman G; Cunha-Vaz JG
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):237-40. PubMed ID: 3979850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular fluorophotometry in diabetic patients without apparent retinopathy.
    Kayazawa F
    Ann Ophthalmol; 1984 Mar; 16(3):221-5. PubMed ID: 6712065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic interpretation of kinetic vitreous fluorophotometry.
    Zeimer RC; Blair NP; Cunha-Vaz JG
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):222. PubMed ID: 3979847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous fluorophotometry in juvenile diabetics after oral fluorescein.
    Nuzzi G; Vanelli M; Venturini I; Bonacini M; Boselli E
    Arch Ophthalmol; 1986 Nov; 104(11):1630-1. PubMed ID: 3778277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.
    Prager TC; Chu HH; Garcia CA; Anderson RE; Field JB; Orzeck EA; Comstock JP
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic vitreous fluorophotometry in normals and noninsulin-dependent diabetics.
    Cunha-Vaz JG; Zeimer R; Wong WP; Kiani R
    Ophthalmology; 1982 Jul; 89(7):751-6. PubMed ID: 7122051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular fluorophotometric analysis.
    Mosier MA; Gray JR; Ishimoto BM
    Curr Eye Res; 1982-1983; 2(10):699-704. PubMed ID: 7186436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrophtal: an instrument for ocular spectrophotometry and fluorophotometry.
    Alvarez Martin P; Galan Nunez M; Martin-Fernandez SG; Gonzalez de la Rosa M
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):206-8. PubMed ID: 3979844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous fluorophotometric evaluation of diabetics.
    Bursell SE; Delori FC; Yoshida A; Parker JS; Collas GD; McMeel JW
    Invest Ophthalmol Vis Sci; 1984 Jun; 25(6):703-10. PubMed ID: 6724841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.